Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-159174
Filing Date
2018-05-10
Accepted
2018-05-10 16:01:58
Documents
62
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d569386d10q.htm 10-Q 743223
2 EX-31.1 d569386dex311.htm EX-31.1 6253
3 EX-31.2 d569386dex312.htm EX-31.2 6234
4 EX-32.1 d569386dex321.htm EX-32.1 4522
11 GRAPHIC g56938637a.jpg GRAPHIC 67082
12 GRAPHIC g56938638a.jpg GRAPHIC 25865
13 GRAPHIC g56938643a.jpg GRAPHIC 21053
  Complete submission text file 0001193125-18-159174.txt   4145672

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20180331.xml EX-101.INS 545033
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20180331.xsd EX-101.SCH 45435
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20180331_cal.xml EX-101.CAL 43548
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20180331_def.xml EX-101.DEF 234296
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20180331_lab.xml EX-101.LAB 385720
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20180331_pre.xml EX-101.PRE 316208
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 18822373
SIC: 2834 Pharmaceutical Preparations